Get the Stockscreener App
0.6412
5.71%
-0.0388
After Hours:
.64
-0.0012
-0.19%
BiomX Inc stock is traded at $0.6412, with a volume of 501.39K.
It is down -5.71% in the last 24 hours and down -79.11% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.68
Open:
$0.6882
24h Volume:
501.39K
Relative Volume:
2.53
Market Cap:
$5.62M
Revenue:
-
Net Income/Loss:
$-36.20M
P/E Ratio:
-0.0269
EPS:
-23.8772
Net Cash Flow:
$-26.39M
1W Performance:
+1.14%
1M Performance:
-79.11%
6M Performance:
-91.35%
1Y Performance:
-93.85%
1-Day Range:
$0.64
$0.71
1-Week Range:
$0.62
$0.93
52-Week Range:
$0.62
$14.71
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.6412 | 5.96M | 0 | -36.20M | -26.39M | -23.88 |
VRTX
Vertex Pharmaceuticals Inc
|
427.65 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.00 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
BiomX subsidiary launches mobile command app for operators By Investing.com - Investing.com Australia
Operators get AI command app that routes alerts in real time - Stock Titan
BiomX Reinvents Itself as Diversified Defense Technology Platform - TipRanks
BiomX (NYSE: PHGE) exits biotech and rebuilds as Israeli defense-tech holding - Stock Titan
BiomX Inc. 2025 Form 10-K/A Annual Report: Executive Team, Compensation, Governance & Financial Disclosures - Minichart
BiomX (NYSE: PHGE) details new board, equity plans and related deals - Stock Titan
PHGE - Finviz
BiomX announces 1-for-19 reverse stock split - MSN
All you need to know about BiomX (PHGE) rating upgrade to buy - MSN
What factors are influencing BiomX Inc. (PHGE) stock today | BiomX Inc. posts 73.7% EPS miss on zero Q4 revenueInvestor Call - Xã Thanh Hà
PHGE Technical Analysis | Trend, Signals & Chart Patterns | BIOMX INC (NYSEARCA:PHGE) - ChartMill
Is BiomX Inc. (PHGE) stock worth entering at this stage (-6.60%) 2026-04-18Trending Volume Leaders - Xã Thanh Hà
Zorronet Delivers 98% Success in Israel Railways Pilot, Awarded Framework Supply Agreement for AI-Powered Detection Systems - The Manila Times
BiomX’s Zorronet Achieves 98% Success in Israel Railways Pilot, Secures AI-Powered Detection Framework Agreement - Minichart
BiomX Subsidiary Zorronet Secures Israel Railways Supply Deal - TipRanks
BiomX subsidiary Zorronet wins framework supply deal with Israel Railways after 98% pilot success - TradingView
BiomX (NYSE American: PHGE) lands Israel Railways AI deal with $1M option - Stock Titan
An AI rail system kept boar and gazelles off tracks 98% of the time - Stock Titan
Deerfield funds (PHGE) report capped 9.99% beneficial stake in BiomX - Stock Titan
BiomX Acquires Majority Stake in DFSL Security Subsidiary - The Globe and Mail
Water IO and T3 Defense report 20.4% stake in BiomX (PHGE) - Stock Titan
BiomX (PHGE) Moves Forward with Acquisition of DFSL - GuruFocus
BiomX Acquires DFSL to Expand AI-Enabled Defense and Security Capabilities with Advanced LADAR Detection Systems 1 - Minichart
BiomX Accelerates Defense Technology Buildout with DFSL Acquisition - The Manila Times
BiomX Buys 60% of DR. Frucht Systems; Pays $750K Cash, $3M Note and 5.54M Shares/Warrants - TradingView
BiomX Inc. Acquires Controlling Interest in DFSL to Enhance Defense and Security Capabilities - Quiver Quantitative
BiomX accelerates exercise of exclusive option to acquire DFSL option - TipRanks
BiomX (NYSE: PHGE) takes control of DFSL with stock, $3M note and warrants - Stock Titan
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications - marketscreener.com
BiomX adds 99%-accurate laser threat tracking in defense push - Stock Titan
BiomX Closes ZorroNet Acquisition, Enters AI Defense Sector - The Globe and Mail
BiomX Inc. Approves 2026 Equity Incentive Plan and Reports Special Meeting Results – SEC Form 8-K Filing - Minichart
T3 Defense completes sale of ZorroNet subsidiary to BiomX for stock and cash - Investing.com Australia
BiomX stockholders approve 2026 equity incentive plan at special meeting By Investing.com - Investing.com Canada
BiomX stockholders approve 2026 equity incentive plan at special meeting - Investing.com
BiomX Stockholders Approve 2026 Equity Incentive Plan - TipRanks
Update Recap: Can BiomX Inc maintain sales growthRate Cut & Step-by-Step Swing Trade Plans - baoquankhu1.vn
BiomX (PHGE) investors back all proposals at April 10 special meeting - Stock Titan
BiomX completes acquisition of AI defense software firm Zorronet By Investing.com - Investing.com Australia
Water IO, T3 Defense (NYSE: PHGE) report 19.9% BiomX ownership - Stock Titan
T3 Defense Gains Strategic BiomX Stake Through Asset Sale - TipRanks
T3 Defense (DFNS) swaps Zorronet for BiomX stake, note and earnout - Stock Titan
Press Release: BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications - 富途牛牛
Transcript : BiomX Inc.Shareholder/Analyst Call - marketscreener.com
BiomX Acquires Zorronet to Expand AI Command-and-Control Capabilities in $81B Defense and Security Market by 2030 1 - Minichart
Biomx Incbuys 100% of Zorronet from Water IOSEC filing - marketscreener.com
BiomX completes acquisition of AI defense software firm Zorronet - Investing.com
BiomX Acquires ZorroNet From Water IO; Pays 1.3M Shares and $1.25M Note - TradingView
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.77%
0.25%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):